Sign up to save your podcasts
Or
Share A go for anti-Nogo-A
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A go for anti-Nogo-A
Pierre-Francois Pradat MD PhD of the Assistance Publique - Hôpitaux de Paris in France talks about GSK's potential ALS medicine ozanezumab, now at phase II. Learn more: http://blogs.als.net/post/2013/04/09/A-Go-For-anti-NOGO-A.aspx
View all episodes
By ALS Today, ALS Therapy Development InstitutePierre-Francois Pradat MD PhD of the Assistance Publique - Hôpitaux de Paris in France talks about GSK's potential ALS medicine ozanezumab, now at phase II. Learn more: http://blogs.als.net/post/2013/04/09/A-Go-For-anti-NOGO-A.aspx